Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson

The CEO is setting a path to transform women’s health at an opportune time.

By Taren Grom • March 30, 2022

Woman of the Week: Genentech's Quita Highsmith

Quita Highsmith is changing how Genentech approaches diversity and inclusion across the board — from drug development to career advancement.

By Taren Grom • March 9, 2022

Ramona Sequeira breaks PhRMA's glass ceiling

A few weeks ago, PhRMA, the industry’s largest trade group, announced that Sequeira has officially become chair of the organization’s board of directors. She is the first woman — and first woman of color — to take on the job.

By Taren Grom • March 7, 2022

Woman of the Week: Lyndra Therapeutics' CEO Dr. Trish Hurter

With Lyndra's ultra-long-acting therapies, Hurter and the company are aiming to reinvent medicines.

By Taren Grom • March 2, 2022

The 2022 PharmaVoice 100 — new look, same drive for excellence

Some of the industry’s biggest names have been on our list of honorees. Now it’s time to find this year’s inspiring leaders.  

By Taren Grom • Feb. 28, 2022

Candel's CEO looks to help ignite a new era of cancer treatments

Candel Therapeutics is advancing a next-gen approach in oncology: using viruses to kill cancer cells at the site of injection.

By Taren Grom • Feb. 28, 2022

Guadalupe Hayes-Mota's 'recipe' for tackling pharma's supply chain issues

A quest to expand access to medical treatment globally led to a new career path when Guadalupe Hayes-Mota left his biotech leadership roles to start his own company. 

By Robin Robinson • Feb. 25, 2022

Woman of the Week: Sumitovant's Chief Business Development and Commercial Officer Adele Gulfo

Adele Gulfo, chief business development and commercial officer at Sumitovant Biopharma, is leaning into her decades of experience to bring a future-focused approach to drug development.

By Taren Grom • Feb. 23, 2022

Saniona's CEO on why it takes a village to develop treatments for a rare disease

Saniona built its village by first hiring a head of patient advocacy.

By Kim Ribbink • Feb. 8, 2022

Ferring Pharmaceuticals president discusses the need for more funding in women's health research

Read why women's healthcare funding is such a challenge.

By Robin Robinson • Feb. 4, 2022

Industry executives predict the next 'blue oceans' in pharma

Where life science leaders see breakthroughs happening in the industry.

By Taren Grom • Feb. 4, 2022

PTC's vice president of patient relations outlines the importance of patient input in rare disease R&D

You can't know what matters to rare disease patients unless you ask them.

By Kim Ribbink • Feb. 3, 2022

New Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality

Read what Capsida CEO Peter Anastasiou has planned for his new role. 

By Taren Grom • Feb. 3, 2022

Woman of the Week: Google Cloud's Andrea McGonigle

Andrea McGonigle, Google Cloud’s general manager, healthcare and life sciences partnerships and strategic initiatives, is intent on bringing technology and innovation together to solve some of the biggest challenges in healthcare.

By Taren Grom • Feb. 2, 2022

Talent acquisition stays top of mind for pharma execs

From creating flexible work environments to looking outside the industry for new talent, pharma execs are shifting strategies to keep their teams afloat.

By Taren Grom • Feb. 1, 2022

For the CEO of Travere, running a rare disease company is personal

To kick off Rare Disease month, we interview the CEO of Travere Therapeutics

By Kim Ribbink • Feb. 1, 2022

Foghorn's CEO on why collaborations are key to unlocking precision medicine

With a major development deal under his belt, Adrian Gottschalk is helping the company advance its innovative platform.

By Robin Robinson • Jan. 28, 2022

Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health

Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.

By Alexandra Pecci • Jan. 23, 2022

Biote CEO breaks down barriers in women's health

Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.

By Robin Robinson • Jan. 11, 2022

Ovid's CEO shares his vision for rare disease developments

Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

By Kim Ribbink • Jan. 10, 2022

How the executive VP of HR at Incyte is tackling pharma's hiring woes

In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.

By Meagan Parrish • Jan. 10, 2022

The Red Jacket awards

The PharmaVoice 100 ‘hall of fame’ winners

By Megan McCoskey • Dec. 22, 2021

PharmaVoice 100 Nomination Form

Recognition for the most inspiring people in the life-sciences industry, as determined by our readers.

By The PharmaVoice Team • Dec. 17, 2021

PharmaVoice 100 Who's on the List – By Category

Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

By PharmaVoice Team • Aug. 1, 2021

Commanders & Chiefs

These forward-thinking leaders are inspiring their teams to achieve far-reaching goals and strategically positioning their companies for success as they navigate complex industry challenges. Be bold Igniting change by… Addressing barriers between patients and their medicines Vict...

By PharmaVoice Team • Aug. 1, 2021